TopFunds

Elevance Health

NYSE: ELV

Stock price

410.95 USD

(+8.28%) 5 years

Managed Health CareMedical - Healthcare Plans

Insider Transactions

5Y price score: 11
Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

5Y return: +8.28%
DATE RANGE:
USD PER SHARE

  • Stock price
  • Sales
  • Purchases
  • Stock awards

Transaction History

Trade log
DateActionSharesPriceShare ValueHoldingNameTitleSource
17-jul.-26Purchase1,000366.1366,05010,908PERU RAMIRO Gdirectorlink
17-jul.-26Purchase2,045368.3753,071171,976BOUDREAUX GAILdirector, officer: President and CEOlink
17-jul.-26Purchase680366.4249,159169,931BOUDREAUX GAILdirector, officer: President and CEOlink
12-jun.-26Sale(369)403.2(148,766)3,740Penczek Ronald Wofficer: CAO & Controllerlink
11-jun.-26Sale(151)401.8(60,667)10,734Dixon Robert L JRdirectorlink
19-may.-26Sale(1,531)403.1(617,192)4,109Penczek Ronald Wofficer: CAO & Controllerlink
13-may.-26Award563--2,209STRABLE-SOETHOUT DEANNA Ddirectorlink
13-may.-26Award563--781SCHULMAN AMY Wdirectorlink
13-may.-26Award563--7,163Schneider Ryan M.directorlink
13-may.-26Award563--9,908PERU RAMIRO Gdirectorlink

274.8

52-week range

436.2

410.95

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Set price notification

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

6.9 %

Dividend Yield TTM

1.7 %

Market cap $

$ 89,122

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

18.3

Price / Book TTM

2

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

(8.4)

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

32.3 %

15.9 %

262.6 %

Free cash flow per share growth

(5.7) %

(62.4) %

11.2 %

Earnings per share growth

(13.1) %

39.7 %

167.8 %

Dividends

Previous dividend:1.72 per share, Paid, Ex-div date Jun 10, 2026
Next dividend:1.72 per share, Declared, Ex-div date Sep 10, 2026

Analyst ratings

Price Target Low

391

Price Target High

498

Price Target Median

456

Buy

27

Hold

11

Sell

0

Financials

all figures in USD Millions except per share data

Periods:

View:

Forecast:

Help

Averages

based on historical growth rates (CAGR) and average margins for last 10 or max, available and up to 10 years.

Analysts

Average Revenue and Net Income forecast estimates from analysts who cover the stock.

Custom

you can edit default forecast based on averages or analysts consensus and use it to calculate fair value based on your assumptions.

ㅤ

Actual
10 year gagr
Estimated
Projected
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
2026
2027
2028
2029
2030
Terminal
FISCAL PERIOD END DATES
SHOW FORECAST VS ACTUAL
01Earnings per share
Help
Diluted EPSLearn more
9.4
9.2
14.4
14.2
18.5
18
24.7
24.3
25.2
25.7
25.1
10.4%
37.2
41.7
46.6
52.2
58.4
61.5
02FCF per share
12.9
9.8
12.7
10.3
19.1
38
29.5
29.8
28.5
19.5
14.3
1.1%
43.8
49.2
55.3
62.1
69.8
73.1
03Dividends per share
Help
Adjusted for splitsLearn more
2.5
2.6
2.7
3
3.2
3.8
4.5
5.1
5.9
6.5
6.8
10.6%
-
-
-
-
-
-
04Dividends payout, %
25.7%
27.7%
18.3%
20.7%
17%
20.9%
18.1%
20.9%
23.3%
25.2%
27%
0.5%
-
-
-
-
-
-
05Revenue
$ 79,240
$ 84,978
$ 90,039
$ 92,105
$ 104,213
$ 121,867
$ 138,639
$ 156,595
$ 171,340
$ 176,810
$ 199,125
9.7%
$ 218,345
$ 239,421
$ 262,531
$ 287,871
$ 315,658
$ 325,128
06ㅤ% Change
-
7.2%
6%
2.3%
13.2%
16.9%
13.8%
13%
9.4%
3.2%
12.6%
9.7%
9.7%
9.7%
9.7%
9.7%
9.7%
9.7%
07Net Income
2,560
2,470
3,843
3,750
4,807
4,572
6,104
5,894
5,987
5,980
5,662
8.3%
8,084
8,865
9,720
10,658
11,687
12,038
08ㅤ% Margin
3.2%
2.9%
4.3%
4.1%
4.6%
3.8%
4.4%
3.8%
3.5%
3.4%
2.8%
3.7% A
3.7%
3.7%
3.7%
3.7%
3.7%
3.7%
09CFO
4,116
3,205
4,185
3,827
6,061
10,688
8,364
8,399
8,061
5,808
4,290
0.4%
10,698
11,731
12,863
14,104
15,466
15,930
10ㅤ% Of revenue
5.2%
3.8%
4.7%
4.2%
5.8%
8.8%
6%
5.4%
4.7%
3.3%
2.2%
4.9% A
4.9%
4.9%
4.9%
4.9%
4.9%
4.9%
11CAPEX
(602.9)
(583.6)
(790.2)
(1,208)
(1,077)
(1,021)
(1,087)
(1,152)
(1,296)
(1,256)
(1,116)
6.4%
(1,187)
(1,262)
(1,342)
(1,428)
(1,518)
(1,615)
12ㅤ% Change
-
(3.2)%
35.4%
52.9%
(10.8)%
(5.2)%
6.5%
6%
12.5%
(3.1)%
(11.2)%
6.4% A
6.4%
6.4%
6.4%
6.4%
6.4%
6.4%
13FCFF
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities (09) – Capital Expenditures (11)Learn more
3,513
2,621
3,395
2,619
4,984
9,667
7,277
7,247
6,765
4,552
3,174
(1)%
9,511
10,468
11,520
12,677
13,947
14,315
14Total assets
63,061
66,387
71,460
72,470
78,254
88,276
97,460
102,755
108,928
116,889
121,494
6.8%
129,728
138,520
147,908
157,933
168,636
180,065
15ㅤ% Change
-
5.3%
7.6%
1.4%
8%
12.8%
10.4%
5.4%
6%
7.3%
3.9%
6.8%
6.8%
6.8%
6.8%
6.8%
6.8%
6.8%
16Total liabilities
40,017
41,287
44,957
43,929
46,526
55,077
61,332
66,425
69,523
75,463
77,468
6.8%
82,718
88,324
94,311
100,702
107,527
114,815
17ㅤ% Of assets
63.5%
62.2%
62.9%
60.6%
59.5%
62.4%
62.9%
64.6%
63.8%
64.6%
63.8%
63.8% A
63.8%
63.8%
63.8%
63.8%
63.8%
63.8%
18Shareholders Equity
23,044
25,100
26,503
28,541
31,728
33,199
36,128
36,330
39,405
41,426
44,026
6.7%
47,010
50,196
53,598
57,230
61,109
65,251
19Net Debt
13,751
11,652
16,323
15,277
16,270
16,098
20,012
18,410
20,128
24,413
23,744
5.6%
-
-
-
-
-
-
20Shares Outstanding
Help
Diluted Weighted-average Shares OutstandingLearn more
272,900
268,100
267,800
254,300
260,300
254,300
246,800
242,800
237,400
232,900
221,800
(2.1)%
217,249
212,791
208,425
204,148
199,959
195,856
21ㅤ% Change
-
(1.8)%
(0.1)%
(5)%
2.4%
(2.3)%
(3)%
(1.6)%
(2.2)%
(1.9)%
(4.8)%
(2.1)%
(2.1)%
(2.1)%
(2.1)%
(2.1)%
(2.1)%
(2.1)%
22ROA
4.1%
3.7%
5.4%
5.2%
6.1%
5.2%
6.3%
5.7%
5.5%
5.1%
4.7%
-
6.2%
6.4%
6.6%
6.8%
6.9%
6.7%
23ROE
11.1%
9.8%
14.5%
13.1%
15.2%
13.8%
16.9%
16.2%
15.2%
14.4%
12.9%
-
17.2%
17.7%
18.1%
18.6%
19.1%
18.5%
24Interest coverage
8.2
7.5
6.7
7.8
9
9.8
11.2
9.9
8.5
7.5
5.8
-
-
-
-
-
-
-
25Dividend Yield
1.8%
1.8%
1.2%
1.2%
1.1%
1.2%
1%
1%
1.3%
1.8%
2%
-
-
-
-
-
-
-
26P/E Ratio
14.3
15.3
15.3
18.1
16.1
17.6
18.4
20.9
18.6
14.3
13.9
-
-
-
-
-
-
-
27Stock price range
123-171
117-148
143-235
216-296
235-317
175-333
288-468
428-547
414-502
366-562
275-453
-
-
-
-
-
-
-
28Market Cap
Help
End of Period Market CapLearn more
36,427
37,919
57,622
66,787
77,169
80,529
113,011
123,113
109,907
85,904
77,752
7.9%
146,649
163,674
182,402
203,002
225,662
-
29FCF Yield
9.6%
6.9%
5.9%
3.9%
6.5%
12%
6.4%
5.9%
6.2%
5.3%
4.1%
(8.2)%
6.5%
6.4%
6.3%
6.2%
6.2%
-
30Average stock price
147.2
132.4
188.9
255.9
276.1
253.9
377.7
487.6
458.2
464.1
363.7
9.5%
675
769.2
875.1
994.4
1,128.5
-
31 CEO
GB
Gail Koziara Boudreaux